Most Read News

In the July-September quarter, Gland Pharma reports a 19.56% YoY decline in consolidated net profit, amounting to Rs 194 crore

The observations stem from a routine cGMP inspection at Dr. Reddy’s formulations manufacturing facility (FTO-3) in Bachupally, Hyderabad, conducted between October 19 and October 27.

The LOA is for the construction of 4 tunnels (total length 1.6km) with ballastless track, among others.

The company's Q2 total income rose to Rs 2,242 crore, compared to Rs 2,231 crore in the same quarter last fiscal year

Designit Tokyo, a step-down subsidiary of Wipro Limited, was voluntarily liquidated with effect from November 13, as per a regulatory filing

Foreign Institutional Investors (FIIs) offloaded equities worth Rs 1,244.44 crore on Tuesday

The First Information Report (FIR) lists Mohit Burman as number sixteen and Gaurav Burman as number eighteen.

The pharmaceutical company announces a consolidated net profit of Rs 369 crore for the September quarter, marking a remarkable increase from Rs 56.8 crore reported a year ago.

Oil prices have fallen to roughly $82 per barrel from around $90.

The company invested approximately Rs 385 crore to increase the installed capacity, funded through internal accruals, and received approval from the Maharashtra Pollution Control Board, Mumbai